Cardionerds: A Cardiology Podcast

Chris Salerno, cardiothoracic surgeon specializing in LVAD implantation and perioperative care, and Mark Belkin, advanced heart failure and hemodynamics expert, discuss right ventricular physiology, perioperative RV protection strategies, hemodynamic optimization, LVAD troubleshooting and parameters, anticoagulation timing, sensitization and transplant implications, long-term complications, and future device innovations.

Kenneth Rosenfield, vascular medicine leader and founder of the PERT concept, discusses modern pulmonary embolism care. He traces PE’s reputation as a master masquerader. He explains the shift from anticoagulation to risk-stratified, multidisciplinary management. He details PERT development, the global consortium and registry, and how teams and data are changing PE workflows.

Dr. Mani Daneshmand, cardiothoracic surgeon who leads transplant and MCS programs at Emory. Dr. Jeff Teuteberg, advanced heart failure/transplant cardiologist and Stanford section chief. They trace LVAD history and anatomy. They compare pump designs and surgical considerations. They review new devices, candidacy criteria, RV failure risks, temporary support strategies, and real-world clinic cases.

Dr. Jon Piccini, a clinical cardiac electrophysiologist and Duke EP director, discusses catheter ablation for atrial fibrillation. He covers who should be considered for ablation and why pulmonary vein isolation is central. The conversation compares energy sources like radiofrequency, cryo, and pulsed-field ablation, reviews procedural setup and mapping, and outlines post-procedure monitoring and complication recognition.

Dr. Shelly Hall, a transplant cardiologist and program leader at Baylor, and Dr. MaryJane Farr, a transplant expert formerly at Columbia, discuss post‑heart transplant care. They cover immunosuppression strategies and monitoring, rejection types and surveillance tools, infection timelines and adjustments, and long‑term complications like cardiac allograft vasculopathy and retransplantation considerations.

Dr. Andrew Epstein, an electrophysiologist and professor at the University of Pennsylvania, dives deep into the world of anti-arrhythmic drugs. He explains the roles of class IC and class III agents in managing atrial fibrillation, detailing their mechanisms, efficacy, and patient selection. The conversation highlights the advantages of drugs alongside catheter ablation, emphasizes monitoring for side effects, and compares treatments like amiodarone and digoxin. Epstein's insights into drug interactions and individualized therapy provide vital knowledge for practitioners.

In this engaging discussion, Dr. Dave Kaczorowski, a cardiothoracic surgeon from UPMC, and Dr. Jason Katz, a transplant cardiologist at NYU, dive into the intricate world of heart transplantation. They explore the critical criteria for donor selection, differences between DBD and DCD organ donors, and the importance of multi-disciplinary teams. The duo also covers post-operative care strategies, including vasoactive management and recognizing complications like cardiac tamponade. Tune in for their insights on expanding donor pools and improving patient outcomes!

Dr. Joshua Cooper, Director of Cardiac Electrophysiology at Temple University and a renowned educator, shares his vast knowledge on atrial flutter. He distinguishes its organized circuit from the chaos of atrial fibrillation and explores their shared pathophysiology. Key discussions include challenges in managing rate control due to AV node conduction, the efficacy of catheter ablation, and the importance of diagnosing flutter early. Cooper emphasizes the need for careful anticoagulation management post-procedure and highlights the educational appeal of flutter for aspiring electrophysiologists.

Dr. Kelly Schlendorf, the Director of Heart Failure and Transplant at Vanderbilt, dives deep into heart transplant evaluations and management. She clarifies the complexities of pre-transplant strategies, exploring bridge techniques like temporary MCS and durable LVAD. The conversation touches on the current heart allocation system, donor-recipient matching, and the role of sensitization in compatibility. Efforts to expand the donor pool, including the use of HCV-positive and HIV-positive organs, highlight the evolving landscape in heart transplantation.

Dr. Edmond Cronin, an electrophysiologist and associate professor, brings his expertise from the 2023 AF guideline writing committee. He discusses the various classifications of atrial fibrillation (AF) and highlights key symptoms beyond palpitations. The conversation delves into the importance of early rhythm control, emphasizing the benefits from recent trials. Dr. Cronin also addresses lifestyle interventions, antiarrhythmic safety, and unresolved questions in AF management, offering listeners a comprehensive view of chronic AF care.